Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Richard Joseph MD

Richard W. Joseph MD

Assistant Professor, Department of Health Science Research, Division of Epidemiology; Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Florida

Dr. Joseph is a Medical Oncologist and clinical/translational researcher at Mayo Clinic Florida (MCF) with the academic rank of Assistant Professor. His clinical and translational research efforts focus on understanding and improving immunotherapy for patients with metastatic melanoma. He is currently a voting member of the National Comprehensive Cancer Network (NCCN) melanoma committee as well as an invited member of the Society of Immunotherapy for the Treatment of Cancer (SITC) ccRCC task force. His research goal is to continue to improve the use of immunotherapy in the fight against cancer.

Recent Contributions to PracticeUpdate:

  1. Expression of PD-1 and PD-L1 in RCC With Sarcomatoid Differentiation
  2. Adjuvant Ipilimumab for High-Risk Melanoma: Pros and Cons
  3. Adjuvant Ipilimumab Improves Recurrence-Free Survival in High-Risk Stage III Melanoma

Most Read This Week

Recently Updated